Identification of a 1,2,4,5‐Tetraoxane Antimalarial Drug‐Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins
Authors:
- Paul M. O'NeillPOPaul M. O'Neill
- Richard K. AmewuRARichard K. Amewu
- Gemma L. NixonGNGemma L. Nixon
- Fatima Bousejra ElGarahFEFatima Bousejra ElGarah
- Mathirut MungthinMMMathirut Mungthin
- James ChadwickJCJames Chadwick
- Alison E. ShoneASAlison E. Shone
- Sant MuangnoicharoenSMSant Muangnoicharoen
- Patrick G. BrayPBPatrick G. Bray
- 28 July 2010
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 49 (33) , 5693-5697
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- New developments in synthetic peroxidic drugs as artemisinin mimicsDrug Discovery Today, 2007
- Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy!Acta Tropica, 2005
- MalariaThe Lancet, 2005
- Identification of an antimalarial synthetic trioxolane drug development candidateNature, 2004
- A Medicinal Chemistry Perspective on Artemisinin and Related EndoperoxidesJournal of Medicinal Chemistry, 2004
- Antimalarial drug resistanceJournal of Clinical Investigation, 2004
- Neue Antimalaria‐WirkstoffeAngewandte Chemie, 2003
- New Antimalarial DrugsAngewandte Chemie International Edition, 2003
- Artemisinin and derivatives: the future for malaria treatment?Current Opinion in Infectious Diseases, 2001